BIO-Key International Inc当前公司基本面数据相对健康,增长潜力稳定。当前估值合理,在电子设备与零部件行业排名46/58位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价2.00。中期看,股价处于下降通道。近一个月,市场表现非常差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。
BIO-Key International Inc评分
相关信息
行业排名
46 / 58
全市场排名
354 / 4562
所属行业
电子设备与零部件
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
1
位分析师
买入
评级
2.000
目标均价
+160.01%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
BIO-Key International Inc亮点
亮点风险
BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.
BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.
公司代码BKYI
公司BIO-Key International Inc
CEODepasquale (Michael W)
网址https://www.bio-key.com/
常见问题
BIO-Key International Inc(BKYI)的当前股价是多少?
BIO-Key International Inc(BKYI)的当前股价是 0.618。
BIO-Key International Inc的股票代码是什么?
BIO-Key International Inc的股票代码是BKYI。
BIO-Key International Inc股票的52周最高点是多少?
BIO-Key International Inc股票的52周最高点是3.680。
BIO-Key International Inc股票的52周最低点是多少?
BIO-Key International Inc股票的52周最低点是0.613。
BIO-Key International Inc的市值是多少?
BIO-Key International Inc的市值是4.52M。
BIO-Key International Inc的净利润是多少?
BIO-Key International Inc的净利润为-4.30M。
现在BIO-Key International Inc(BKYI)的股票是买入、持有还是卖出?
根据分析师评级,BIO-Key International Inc(BKYI)的总体评级为买入,目标价格为2.000。
BIO-Key International Inc(BKYI)股票的每股收益(EPS TTM)是多少
BIO-Key International Inc(BKYI)股票的每股收益(EPS TTM)是-0.898。